TY  - CONF

T1  - Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)

JO  - JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

PY  - 2021/10/01

AU  - Lee MM

AU  - Allwood-Spiers S

AU  - Barrientos PH

AU  - Wetherall K

AU  - Mcconnachie A

AU  - Welsh P

AU  - Roditi G

AU  - Sourbron S

AU  - Radjenovic A

AU  - McMurray J

AU  - Jhund P et al

ED  - 

VL  - 32

IS  - 10

SP  - B12

EP  - B12

Y2  - 2025/12/05

ER  -